Phototherapies: photosensitized inactivation of viral and protozoan infectious agents and potential application in blood banking

More than 10 million units of human blood components are processed annually in the United States. Although donor screening and testing have greatly lowered the risk of transmission of viral and protozoan infectious agents, additional sterilization procedures which also preserve blood component function would be of significant value. Use of UV-A and visible-light-range photosensitizers for sterilization of blood platelets and red blood cells, respectively, is currently being aggressively investigated in laboratory-scale optical-mechanical systems. With successful demonstration of the efficacy and safety of these sterilization techniques, implementation in the blood bank setting will require scale-up to optical-mechanical systems capable of handling approximately 25,000 units daily in 500 - 1,000 blood banks in the United States.

[1]  R. Purcell,et al.  Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. , 1972, Annals of internal medicine.

[2]  J. Matthews,et al.  Protection of NIH 3T3 cells from infection by trypomastigotes and sphaeromastigotes of Trypanosoma cruzi, Telahuen strain, by porphyrins in the presence and absence of light (630 and 690 nm). , 1989, The Journal of parasitology.

[3]  J. R. Lindberg,et al.  Freeze-preserved baboon red blood cells: effects of biochemical modification and perfusion in vitro. , 1981, American journal of veterinary research.

[4]  J. Newman,et al.  Inactivation of viruses with photoactive compounds. , 1992, Blood cells.

[5]  R. Purcell,et al.  Association of EB-virus infection with the post-perfusion syndrome. , 1969, Lancet.

[6]  J. Sessler,et al.  In vitro PHOTODYNAMIC INACTIVATION OF Herpes simplex VIRUS WITH SAPPHYRINS: 22 π‐ELECTRON PORPHYRIN‐LIKE MACROCYCLES , 1991, Photochemistry and photobiology.

[7]  J. Fratantoni,et al.  Effects of two viral inactivation methods on platelets: laser-UV radiation and merocyanine 540-mediated photoinactivation. , 1992, Blood cells.

[8]  R. Purcell,et al.  Transfusion‐associated hepatitis not due to viral hepatitis type A or B † , 1975, The New England journal of medicine.

[9]  D. Gaffney,et al.  MODULATION BY THIOLS OF THE MEROCYANINE 540‐SENSITIZED PHOTOLYSIS OF LEUKEMIA CELLS, RED CELLS, AND Herpes simplex VIRUS TYPE 1 , 1991, Photochemistry and photobiology.

[10]  C. Valeri,et al.  Liquid and freeze preservation of baboon platelets. , 1981, Cryobiology.

[11]  Alan R. Morgan,et al.  The Diels-Alder reactions of protoporphyrin IX dimethyl ester with electron-deficient alkynes , 1986 .

[12]  J. Newman,et al.  Preliminary studies of photoinactivation of human immunodeficiency virus in blood , 1991, Transfusion.

[13]  S. Sharkis,et al.  Inactivation of Friend erythroleukemia virus and Friend virus-transformed cells by merocyanine 540-mediated photosensitization. , 1989, Blood.

[14]  R. Betts,et al.  Viral Serology (Hepatitis B Virus, Cytomegalovirus, Epstein‐Barr Virus) and Abnormal Liver Function Tests in Transfused Patients with Hereditary Hemorrhagic Diseases , 1979, Transfusion.

[15]  A. Welch,et al.  Is there an optimal laser treatment for port wine stains? , 1986, Lasers in surgery and medicine.

[16]  J. Newman,et al.  Photodynamic therapy of viral contaminants with potential for blood banking applications , 1988, Transfusion.